Ikarian Capital, LLC Portfolio Holdings

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Ikarian Capital, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $573 Million distributed in 145 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Tarsus Pharmaceuticals, Inc. with a value of $33.9M, Crinetics Pharmaceuticals, Inc. with a value of $21.8M, Bei Gene, Ltd. with a value of $19.8M, Viridian Therapeutics, Inc.\De with a value of $11.4M, and Arcus Biosciences, Inc. with a value of $11.4M.

Examining the 13F form we can see an increase of $325M in the current position value, from $247M to 573M.

Ikarian Capital, LLC is based out at Dallas, TX

Below you can find more details about Ikarian Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $573 Million
Healthcare: $523 Million
ETFs: $49.4 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.45B
$33.9 Million 5.92% of portfolio
1,030,277
Q3 2024 Added 28.74%
$785M
$11.4 Million 1.99% of portfolio
499,977
Q3 2024 New
$1.15B
$11.4 Million 1.99% of portfolio
744,000
Q3 2024 Added 413.1%
$942M
$5.84 Million 1.02% of portfolio
260,000
Q3 2024 Reduced 40.98%
$522M
$4.91 Million 0.86% of portfolio
693,350
Q3 2024 New
$344M
$4.56 Million 0.8% of portfolio
300,000
Q3 2024 New
$1.14B
$4.46 Million 0.78% of portfolio
544,265
Q3 2024 Reduced 5.36%
$608M
$4.18 Million 0.73% of portfolio
258,279
Q3 2024 New
$865M
$3.64 Million 0.64% of portfolio
197,096
Q2 2024 Reduced 33.66%
$363M
$1.73 Million 0.3% of portfolio
202,908
Q3 2024 Reduced 33.01%
$334M
$1.65 Million 0.29% of portfolio
311,593
Q3 2024 New
$481M
$1.24 Million 0.22% of portfolio
476,586
Q1 2024 Added 15.43%
$440M
$823,000 0.14% of portfolio
1,068,992
Q3 2024 Added 23.02%
$354M
$822,000 0.14% of portfolio
170,000
Q3 2024 New
$539M
$563,000 0.1% of portfolio
49,415
Q1 2024 Added 0.78%
$580M
$191,000 0.03% of portfolio
83,282
Q3 2024 Reduced 76.76%

Summary

  • Portfolio
  • No. of Stocks 145
  • Current Value $573 Million
  • Prior Value $247 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 21 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 28 stocks
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email